India's Strides Arcolab, Eli Lilly in generic cancer drug tie-up
Posted on December 05, 2012 at 05:23 AM EST
MUMBAI, Dec 5 (Reuters) - India's Strides Arcolab and Eli Lilly will jointly manufacture and distribute generic cancer drugs for developing markets, the drugmakers said on Wednesday, as the U.S. company looks to expand its presence in emerging markets.